Conduent (CNDT) vs OptimizeRx (OPRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Conduent (CNDT) has outperformed OptimizeRx (OPRX) over the past year, losing 43.3% versus a loss of 54.1%. Over five years, CNDT leads with a -76.7% price change compared with -90.1% for OPRX. Conduent is the larger company by market cap ($244.2 million vs $157.8 million), about 1.5 times the size.
On valuation, OptimizeRx trades at a lower forward P/E (8.0x vs 157.0x for Conduent).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNDT | OPRX |
|---|---|---|
| Share price | $1.57 | $8.38 |
| Market cap | $244.17M | $157.85M |
| 1-day change | -1.88% | -1.99% |
| YTD return | -18.23% | -31.65% |
| 1-year return | -43.32% | -54.06% |
| 5-year return | -76.71% | -90.10% |
| P/E ratio (TTM) | — | 34.92 |
| Forward P/E | 157.00 | 8.03 |
| EPS (TTM) | $-1.16 | $0.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.67 | $22.25 |
| 52-week low | $1.15 | $4.54 |
| Distance from 52-week high | -41.09% | -62.34% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +218.47% | +50.36% |
| Average volume | 1.01M | 203.38K |
| Shares outstanding | 155.52M | 18.84M |
| Employees | 46,000 | 132 |
| Sector | Consumer Discretionary | Healthcare |
| Industry | Business Services | Health Information Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CNDT has outperformed OPRX by 10.7 percentage points over the past year.
- The two companies sit in different sectors: Conduent in Consumer Discretionary and OptimizeRx in Healthcare.
About Conduent
CNDT stock →Conduent Incorporated provides digital business solutions and services for the commercial, government, and transportation spectrum in the United States, Europe, and internationally. It operates through three segments: Commercial, Government, and Transportation.
Consumer Discretionary · Business Services · 46,000 employees
About OptimizeRx
OPRX stock →OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail.
Healthcare · Health Information Services · 132 employees
CNDT vs OPRX FAQ
Which is bigger, Conduent or OptimizeRx?
Conduent (CNDT) is larger, with a market capitalization of $244.17M compared with $157.85M for OptimizeRx (OPRX).
Which stock has performed better over the past year, CNDT or OPRX?
CNDT returned -43.32% over the past 12 months, compared with -54.06% for OPRX (price return, excluding dividends). Past performance does not predict future results.
Are Conduent and OptimizeRx in the same industry?
No. Conduent is in the Consumer Discretionary sector, while OptimizeRx is in Healthcare.